Bionano Genomics (BNGO) Expected to Announce Quarterly Earnings on Thursday

Posted by Defense World Staff on Aug 12th, 2025

Bionano Genomics (NASDAQ:BNGO – Get Free Report) is expected to issue its Q2 2025 quarterly earnings data after the market closes on Thursday, August 14th. Analysts expect the company to announce earnings of ($2.69) per share and revenue of $6.90 million for the quarter. Bionano Genomics has set its Q2 2025 guidance at EPS.

Bionano Genomics (NASDAQ:BNGO – Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported ($1.15) EPS for the quarter, beating analysts’ consensus estimates of ($3.49) by $2.34. The business had revenue of $6.46 million during the quarter, compared to analyst estimates of $6.25 million. Bionano Genomics had a negative net margin of 294.05% and a negative return on equity of 125.75%.

Bionano Genomics Stock Performance

Shares of BNGO stock opened at $2.93 on Tuesday. The firm has a market capitalization of $9.84 million, a PE ratio of -0.02 and a beta of 2.06. The firm has a fifty day simple moving average of $3.35 and a two-hundred day simple moving average of $3.85. The company has a current ratio of 1.70, a quick ratio of 1.34 and a debt-to-equity ratio of 0.07. Bionano Genomics has a 12 month low of $2.68 and a 12 month high of $37.09.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Bionano Genomics from a “sell” rating to a “hold” rating in a research note on Saturday. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat.com, Bionano Genomics currently has an average rating of “Hold” and an average price target of $7.00.

Read Our Latest Stock Report on BNGO

Bionano Genomics Company Profile

(Get Free Report)

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.